TECON(SZ:002100)2022-12-07 08:31Group 1: Company Structure and Operations - The company has completed the acquisition of its controlling shareholder, forming a full industry chain structure including biological vaccines for livestock, feed and plant protein, breeding of breeding pigs, pig farming, slaughter processing, and meat product sales in Xinjiang [2]. Group 2: Business Performance and Growth - The government tender for vaccines is maintaining stable growth, while market-oriented marketing is striving for breakthroughs [3]. - The plant protein business is operating normally, effectively controlling operational risks, and is expected to maintain profitability [3]. - Future profit growth is anticipated to focus on the biopharmaceutical and breeding sectors [3]. Group 3: International Collaboration - Currently, there are no overseas cooperation intentions, but there may be future contacts in this area [3].